Notice2024-10358
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 13, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 93 (Monday, May 13, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 93 (Monday, May 13, 2024)]
[Notices]
[Pages 41441-41442]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-10358]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-23HS]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Survey of Syringe Services
Programs (NSSSP)'', to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
May 4, 2023, to obtain comments from the public and affected agencies.
CDC received two public comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Program Evaluation for PS22-2208 Component 2--New--National Center
for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention, Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
PS22-2208 Component 2 (Strengthening Syringe Services Programs)
serves as a coordinated and accountable mechanism for distribution of
funding to syringe services programs (SSPs) to support implementation
and expansion of services in areas of the United States, Territories,
and Tribal Nations disproportionately affected by infectious disease
consequences of injection drug use. Project activities will directly
contribute to establishing and expanding a national SSP infrastructure
and prevention of infectious disease consequences of drug use. CDC has
funded the National Alliance of State and Territorial AIDs Directors
(NASTAD) to implement this project. NASTAD, in partnership with
University of Washington will collect monitoring and evaluation data
from funded SSPs through their internal mechanisms, both for their
internal evaluation as well as to report semi-annual and annual project
performance reports and stratified aggregate data to CDC. The primary
purpose of this information collection is to monitor and evaluate the
PS22-2208 Component 2 funding opportunity's overall goal of supporting
SSP subrecipients in meeting the needs of people who use drugs (PWUD)
and reducing infectious disease and other harms related to drug use.
During the first year of this Cooperative Agreement, all PS22-2208
SSP subrecipients will be sent a 25-minute baseline program evaluation
survey at the start of project implementation, and a 15-minute
quarterly program evaluation survey in the following three quarters of
the project period. For Years 2-5, new PS22-2208 SSP subrecipients will
be sent the baseline survey at the start of project implementation, and
all existing subrecipients will receive the quarterly program
evaluation survey in the following three quarters of the project
period. SSP subrecipients will primarily complete the survey online in
REDCap, with options to complete via telephone or videoconferencing
modalities. Subrecipients will be asked to complete the surveys within
one month of receipt and will receive weekly reminders until the survey
is complete. SSP subrecipients may be reminded informally during
meetings with NASTAD and may also work with their NASTAD point-of-
contact to determine an alternate method of survey completion. The
survey will include questions on operational and programmatic
characteristics, and quantity of prevention and treatment services
provided in-person, through tele-health, and through navigation to off-
site care, during the specified evaluation period.
Approximately 200 SSPs will participate in the survey. We estimate
that it will take 70 minutes for each SSP
[[Page 41442]]
to complete the baseline survey and three quarterly surveys, regardless
of how the respondent chooses to complete it (i.e., self-administered
online or NASTAD staff-administered by phone or videoconferencing). CDC
requests OMB approval for an estimated 233 annual burden hours. There
is no cost to survey participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondent Form Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs................ Strengthening Syringe 200 1 25/60
Services Programs
Baseline Survey.
All participating SSPs................ Strengthening Syringe 200 3 15/60
Services Programs
Quarterly Survey.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-10358 Filed 5-10-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on May 13, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.